Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Incobotulinumtoxin A by Merz Therapeutics for Unspecified Dermatological Disorders: Likelihood of Approval
Incobotulinumtoxin A is under clinical development by Merz Therapeutics and currently in Phase I for Unspecified Dermatological Disorders. According to...
Data Insights
Incobotulinumtoxin A by Merz Therapeutics for Unspecified Musculoskeletal Disorders: Likelihood of Approval
Incobotulinumtoxin A is under clinical development by Merz Therapeutics and currently in Phase II for Unspecified Musculoskeletal Disorders. According to...